These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 18358251

  • 1. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA, Kulkarni KD.
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [Abstract] [Full Text] [Related]

  • 2. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 3. Therapy for type 2 diabetes mellitus.
    Elson DF, Meredith M.
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [Abstract] [Full Text] [Related]

  • 4. Type 2 diabetes: stepped-care approach to patient management.
    McFarland KF.
    Geriatrics; 1997 Oct; 52(10):22-6, 35, 39. PubMed ID: 9337803
    [Abstract] [Full Text] [Related]

  • 5. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations.
    Gottesman I.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S17-22. PubMed ID: 15315866
    [Abstract] [Full Text] [Related]

  • 6. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J.
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [Abstract] [Full Text] [Related]

  • 7. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 8. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 9. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH.
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L.
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [Abstract] [Full Text] [Related]

  • 11. [Insulin in the treatment of type 2 diabetes].
    Meyer L, Guerci B, Ziegler O, Drouin P.
    Rev Prat; 1999 Jan 01; 49(1):51-5. PubMed ID: 9926717
    [Abstract] [Full Text] [Related]

  • 12. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ.
    Curr Med Res Opin; 2004 Apr 01; 20(4):541-53. PubMed ID: 15119992
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB, Fonseca VA, Truitt KE, Jones MR.
    Arch Intern Med; 2008 Jul 28; 168(14):1531-40. PubMed ID: 18663165
    [Abstract] [Full Text] [Related]

  • 14. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA.
    Acta Diabetol; 2008 Dec 28; 45(4):253-68. PubMed ID: 18766296
    [Abstract] [Full Text] [Related]

  • 15. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Dec 28; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 16. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M, Orsini-Federici M.
    Diabetes Care; 2008 Feb 28; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [Abstract] [Full Text] [Related]

  • 17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y, Guo XH, Vaz JA, PRESENT Study Group.
    Diabetes Obes Metab; 2009 Jan 28; 11(1):33-40. PubMed ID: 18494806
    [Abstract] [Full Text] [Related]

  • 18. Management of diabetes in the real world: tight control of glucose metabolism.
    Spellman CW.
    J Am Osteopath Assoc; 2003 Aug 28; 103(8 Suppl 5):S8-13. PubMed ID: 12962204
    [Abstract] [Full Text] [Related]

  • 19. Understanding new pharmacologic therapy for type 2 diabetes.
    Gutowski C.
    Nurse Pract; 1999 Jun 28; 24(6):15-8, 21-2, 24-5; quiz 26-7. PubMed ID: 10431294
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME.
    J Cardiopulm Rehabil Prev; 2007 Jun 28; 27(4):193-201. PubMed ID: 17667012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.